Further, the increase in the [64Cu]NOTA-CD8a tumor-to-heart ratio in tumors of mice treated with XRT and anti-CTLA-4 matched the increased number of CD45+CD8a+ cells detected by flow cytometry in this treatment group. This evidence concerns the gene PTPRC and neoplasm.